{"name":"Bexion Pharmaceuticals, Inc.","slug":"bexion-pharmaceuticals-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi9gFBVV95cUxNQmVQMTFxeVVDOGdvN29DUW15VnRVTHgxR1VMVXgyTTJ1TFl3V05HTVJWY3VCWGFXZXlYMnUzMThYRkFic1pFWWUzWFRteTRZdFVxNkk2RGpxQXd0NGNKaWg3ZTUyR3JQTVpHbHBlZGZ3SHc0ZGU0U1l3TmtoN3laM2Y3NXNkVUxqWFhRV0xRd2pWLUVSNFJFQ05oZjBIeEhCSUFhVTdQY3R6bEQzTksyNDV4LWpvRUZoU2M2bmZHMmp0dDliRHJvMU9QWEJ6b1BndWJxb3NvWWRxWjA0cXpia012dDlyR25POXZid0JISC1uU0VKX2c?oc=5","date":"2026-04-01","type":"trial","source":"Barchart.com","summary":"Glioma Clinical Trial Pipeline Appears Robust With 180+ Key Pharma Companies Actively Working in the Domain | DelveInsight - Barchart.com","headline":"Glioma Clinical Trial Pipeline Appears Robust With 180+ Key Pharma Companies Actively Working in the Domain | DelveInsig","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAJBVV95cUxORUxnaVZLVkVqM1JyNHF1ejl6c1ZkRnJrMWZsUUdCS3R4aXpSbVRZWE9la0l6NVY0UnFlYWlrczZ2Szd0dnJFMjVJdHNvc29JR2gyck5PcHZ2bWN5UldLRU9fMzk0TDUwTl9naGd4RFA4bm9LQ3phYmZGWjhHZjZyNktVUU82ck50ZkVwUmRpejlwNUxrNExQRmhmMTlqT2U5cjdRQkh5UFlpSFJPelBoVDRGcjBTZkdqcmNEQ1VCdEtYcm5KZTFxUTJFYnZsVG8yMEg3ckgxZW1wQjhXejhZLUJQcmNVeHJJb0piVEc2Z3IwTkRIS1ZoWU1IcHBOcXZZbmxySlY1QTdwdVUwQVItck5JbzVpcElEcVpldElNOW1WNGlORU5LNUstaVA?oc=5","date":"2026-01-06","type":"pipeline","source":"PR Newswire","summary":"Bexion Pharmaceuticals, Inc. Announces Poster Presentations at the American Society for Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium 2026 - PR Newswire","headline":"Bexion Pharmaceuticals, Inc. Announces Poster Presentations at the American Society for Clinical Oncology (ASCO) Gastroi","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggJBVV95cUxNR1Z2azhPVktlRk80TjNMSzFrQmFLVEtDalh5SXFOMk9zY3EtV0FzcGVxaUZKbmN0b2pKV3VrSHVYOGxZd1RQWlNuZ2FfOHE5YVZ3RS10R0pGcDZZb3RzS291b1MzLVV0WDFJQ1ZZUGdWSEI3OW9uaHFyZGFZZW93SURtODMwc19iazBvNUF3cFlkM0xBOEs1ZE9mbHljQkxabFhtMXU2TDAzZjZORVB4SGJ2TXQzZjlkRWdKN01zaThMc1dkRFFHMGtnYVV5MGhPdVVKOVpuRXh6cTU2dUVoZjVIamJfS3N1RVo2aWNzeDk4ZDBSWXN0V3NWZmlaUUFvRFE?oc=5","date":"2024-11-18","type":"regulatory","source":"PR Newswire","summary":"Bexion Pharmaceuticals, Inc. Announces Completion of Enrollment in Open Label Portion of Phase 1b/2 ASIST Study in mCRC - PR Newswire","headline":"Bexion Pharmaceuticals, Inc. Announces Completion of Enrollment in Open Label Portion of Phase 1b/2 ASIST Study in mCRC","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4wFBVV95cUxOOF9odEJieWJ0LWliMHcyZDFxUWtKZVctV1hBWUZxOFBzX0RmdE9idlAyTlRmR2FTcTVKQUc5TWU0OGJ0YUl1YllBX2N4M1djQmhrbWhmcll2NElmd0N5bEF0LUdxaWxDeEFjaUhKWmlhQ1hZd2NnV0hLWkd2UF9YdU4takJBQXlwX3dlS0F4OUVITzZsdjVXVUN0a2UtVnM4U25ZYkN2WGNaRlo0Vm9GS3U0QTA5SjFzZlpZbUZOajh0b2hUYW5oVW93bXlISkRoRy1va0ZkMEswTDNfaS1WMmI3VQ?oc=5","date":"2024-11-14","type":"pipeline","source":"PR Newswire","summary":"Bexion Pharmaceuticals, Inc. Awarded Grant from The Michael J. Fox Foundation to Advance BXQ-350 - PR Newswire","headline":"Bexion Pharmaceuticals, Inc. Awarded Grant from The Michael J. Fox Foundation to Advance BXQ-350","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxObGlPS2ZZUlRyeGN5MnMyTUNRWEN2UkNETTduYlROeXVoYTlYVHJicGlwa3BUQ21QNnN2RDdzdUU1UHlRcU5DRjQtaW9ueUxPUHhYZXJjcmVXSU1saGVTcDI0b3FjcEg4LUJsRFpNVkxpZHNpRlZteHZNYzJNTVA2OUlWQmhDZ1NHZ3RwY2E3bkhSQTlUZEtXdmNjZFhXMW1MeEJrS2w1Ry1uQU5KOEZQNC1ORGNKYm9hcVE?oc=5","date":"2024-02-28","type":"pipeline","source":"Contract Pharma","summary":"Bexion Pharmaceuticals Welcomes Dr. Tariq Arshad as Chief Medical Officer - Contract Pharma","headline":"Bexion Pharmaceuticals Welcomes Dr. Tariq Arshad as Chief Medical Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2gFBVV95cUxQc2twdWRkV0hJY2JMWm5Id1RxT3FYdUhlbU0yNVhucW8yeG5Xbzg3eWN1SlZJV0c2UW5kM2d4emtfV3BGcmpGc2FJYWxZRUVZdS0wUlFTWkQyNDFxNXBqbjZFNkh3LVZ6ejd4SkJsY19KOEQyazJVRkVPZUpVb0tnZkljTG43ZzFhVlRGR3dFN1pxTm9BcW5oQV9uX0FPN2o4Vk1heHFvTzdFTngycjUwd2RXNS1hdWwwQWU3S3pvb0tCM2gxVVh4dmptMFFBbjdNczY4MUpwTnFoUQ?oc=5","date":"2023-10-10","type":"pipeline","source":"PR Newswire","summary":"Bexion Pharmaceuticals, Inc. Appoints Dr. Catherine Pearce, DHSc, MBA, to Board of Directors - PR Newswire","headline":"Bexion Pharmaceuticals, Inc. Appoints Dr. Catherine Pearce, DHSc, MBA, to Board of Directors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxPQjM2R1lfM0RqQnU0U3gtX3JvR2dyeHBBVnRCY3J6SFpIOHFva2ZvNEVnMmFWNGhNTDRxczVaRE1KYjRQd1FQRDNBeF9Ndkk0ZUVIYzZ0bklYZE9fQ3pnZlZ0alZGQXdUeGRNZ3BuZUF1TmpmNjVPblZDcGVWZXNaWERySlVuRVlhYnlFUURvSWlHM1IzdTF0RjBsOVhobEw5RlVFeEtFZmFPTVREYlN6bThZSl92dTN1R1BqZVY5NWNzUQ?oc=5","date":"2022-02-06","type":"pipeline","source":"Northern Kentucky Tribune","summary":"Bexion Pharmaceuticals make leadership changes, names Richard 'Scott' Shively new president/CEO - Northern Kentucky Tribune","headline":"Bexion Pharmaceuticals make leadership changes, names Richard 'Scott' Shively new president/CEO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgJBVV95cUxQdGZHU3RMeHJIeTZBMjRrTFlNai1WcW1RVHhVQy1FY1JoMjNuQjFKSzZGZkZhMEdCSHRMRWt1RjhlS21zMW1tV2tfb1lrUXJONGpnWWR4TDdlVTNLbFo4UnFIY3dFMHpoaE5sMnUxMHFaNE1XNV9ibk9jQ1NfaWU5TjBucHBldEF1X0c2UHZKaTQ0aW1Rc1ZhVnNBNXdjOTFoNkJtN1BBOHJqaDVfN2w3eGFYQlFXbmExUW4tb05SYVJ6LWZET2lFQ2tZZ1R1S3dja1BHWjdmaU9FVXJQZjVYWkxnckE1VVNSeF9jWncxZjRTNmxWVmFBSjE0VTRQSkYyNzc5ZkJFOWxreDBmTUE?oc=5","date":"2019-02-22","type":"trial","source":"PR Newswire","summary":"Bexion Pharmaceuticals Announces the Opening of Phase I Part 3 First-in-Human Trial Using BXQ-350 for the Treatment of Cancer - PR Newswire","headline":"Bexion Pharmaceuticals Announces the Opening of Phase I Part 3 First-in-Human Trial Using BXQ-350 for the Treatment of C","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}